HC Wainwright & Co. Reiterates Buy on NRX Pharmaceuticals, Maintains $19 Price Target
NRX Pharmaceuticals Analyst Ratings
D. Boral Capital Maintains Buy on NRX Pharmaceuticals, Maintains $31 Price Target
NRX Pharmaceuticals Analyst Ratings
EF Hutton Initiates Coverage On NRX Pharmaceuticals With Buy Rating, Announces Price Target of $31
NRX Pharmaceuticals Analyst Ratings
HC Wainwright & Co. Maintains Buy on NRX Pharmaceuticals, Adjusts Price Target To $19 (1-10 Reverse Stock Split)
NRX Pharmaceuticals Analyst Ratings
NRX Pharmaceuticals Analyst Ratings
Ascendiant Capital Maintains Buy on NRX Pharmaceuticals, Lowers Price Target to $43
Buy Rating Affirmed for NRX Pharmaceuticals Amid Promising Outlook for Novel Depression Treatment NRX-100
Analysts Are Bullish on These Healthcare Stocks: HCA Healthcare (HCA), NRX Pharmaceuticals (NRXP)
H.C. Wainwright Sticks to Their Buy Rating for NRX Pharmaceuticals (NRXP)
HC Wainwright & Co. Reiterates Buy on NRX Pharmaceuticals, Maintains $2 Price Target
Ascendiant Remains a Buy on NRX Pharmaceuticals (NRXP)
NRX Pharmaceuticals Analyst Ratings
HC Wainwright & Co. Reiterates Buy on NRX Pharmaceuticals, Maintains $2 Price Target
H.C. Wainwright Sticks to Their Buy Rating for NRX Pharmaceuticals (NRXP)
H.C. Wainwright Remains a Buy on NRX Pharmaceuticals (NRXP)
Analysts Offer Insights on Healthcare Companies: NRX Pharmaceuticals (NRXP) and Arcutis Biotherapeutics (ARQT)